Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection

A M Brooks1, J T McBride, K M McConnochie

  • 1Department of Pediatrics, Children's Hospital at Strong, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. jazbrooks@msn.com

Pediatrics
|September 2, 1999
PubMed

Insights

Clinical deterioration is uncommon in previously healthy infants hospitalized with respiratory syncytial virus (RSV) infection. While extreme tachypnea and hypoxemia predict deterioration, their low sensitivity limits clinical usefulness for early identification.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Respiratory Syncytial Virus (RSV) is a common cause of hospitalization in infants.
  • Clinical deterioration requiring Pediatric Intensive Care Unit (PICU) transfer can occur in previously healthy infants with RSV infection.
  • Identifying infants at risk for deterioration is crucial for timely intervention.

Purpose of the Study:

  • To estimate the incidence of clinical deterioration leading to PICU transfer in previously healthy infants with RSV infection.
  • To assess if initial clinical findings (history, physical exam, oximetry, chest X-ray) can predict such deterioration.

Main Methods:

  • Retrospective analysis of infants aged <=1 year hospitalized with RSV infection (1985-1994).
  • Index patients were previously healthy infants transferred to the PICU; matched with controls not requiring PICU transfer.
  • Comparison of respiratory rate, O2 saturation, wheezing, and chest X-ray findings at presentation.

Main Results:

  • 1.8% of previously healthy infants with RSV infection required PICU transfer.
  • Infants transferred to PICU had modestly abnormal respiratory rates and O2 saturation at presentation.
  • High respiratory rate (>80) and low O2 saturation (<85%) showed high specificity but low sensitivity for predicting deterioration.

Conclusions:

  • PICU admission due to clinical deterioration is infrequent in previously healthy infants with RSV infection on general pediatric units.
  • Extreme tachypnea and hypoxemia are associated with deterioration but have limited predictive value due to low sensitivity.
  • Current clinical parameters have limited usefulness in accurately identifying all infants who will deteriorate.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...